Location History:
- South Austrailia, AU (2019 - 2020)
- Meadows, AU (2017 - 2021)
Company Filing History:
Years Active: 2017-2021
Title: Denis Bernard Scanlon: Innovator in Radiopharmaceuticals
Introduction
Denis Bernard Scanlon is a prominent inventor based in South Australia, AU. He has made significant contributions to the field of radiopharmaceuticals, holding a total of 5 patents. His work focuses on developing compounds that serve as metal ligands, which are crucial in medical applications.
Latest Patents
One of his latest patents is titled "Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals." This invention relates to compounds that are useful as metal ligands and either contain a molecular recognition moiety or can be bound to one. The compounds, once coordinated with a suitable metallic radionuclide, are valuable in radiotherapy and diagnostic imaging. The invention also encompasses methods of diagnosis and therapy utilizing the radiolabelled compounds.
Career Highlights
Denis Scanlon is affiliated with the University of Melbourne, where he continues to advance research in his field. His innovative work has positioned him as a key figure in the development of new radiopharmaceuticals.
Collaborations
He has collaborated with notable colleagues such as Paul Stephen Donnelly and Michelle Therese Ma, contributing to the advancement of research in radiopharmaceuticals.
Conclusion
Denis Bernard Scanlon's contributions to the field of radiopharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to impact the areas of radiotherapy and diagnostic imaging significantly.